Nang Kuang Pharmaceutical Co., Ltd.

TWSE:1752 Voorraadrapport

Marktkapitalisatie: NT$4.5b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Nang Kuang Pharmaceutical Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Yu-Bei Wang

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO3.5%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Nang Kuang Pharmaceutical Co., Ltd.'s (TWSE:1752) 28% Price Boost Is Out Of Tune With Earnings

May 22
Nang Kuang Pharmaceutical Co., Ltd.'s (TWSE:1752) 28% Price Boost Is Out Of Tune With Earnings

Some Investors May Be Willing To Look Past Nang Kuang Pharmaceutical's (TWSE:1752) Soft Earnings

Apr 02
Some Investors May Be Willing To Look Past Nang Kuang Pharmaceutical's (TWSE:1752) Soft Earnings

Nang Kuang Pharmaceutical (GTSM:1752) Has A Pretty Healthy Balance Sheet

Mar 20
Nang Kuang Pharmaceutical (GTSM:1752) Has A Pretty Healthy Balance Sheet

Should You Or Shouldn't You: A Dividend Analysis on Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)

Mar 03
Should You Or Shouldn't You: A Dividend Analysis on Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)

Declining Stock and Decent Financials: Is The Market Wrong About Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)?

Feb 13
Declining Stock and Decent Financials: Is The Market Wrong About Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)?

Nang Kuang Pharmaceutical's (GTSM:1752) Stock Price Has Reduced 17% In The Past Five Years

Jan 26
Nang Kuang Pharmaceutical's (GTSM:1752) Stock Price Has Reduced 17% In The Past Five Years

Estimating The Fair Value Of Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)

Jan 08
Estimating The Fair Value Of Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)

Here's How We Evaluate Nang Kuang Pharmaceutical Co., Ltd.'s (GTSM:1752) Dividend

Nov 29
Here's How We Evaluate Nang Kuang Pharmaceutical Co., Ltd.'s (GTSM:1752) Dividend

CEO

Yu-Bei Wang

no data

Tenure

Ms. Yu-Bei Wang serves as General Manager of Nang Kuang Pharmaceutical Co., Ltd. She co-founded Nang Kuang Pharmaceutical Company in 1963 and served as its General Manager. Ms. Wang serves as a Director of...